The present invention relates to novel heterocyclic compounds of Formulae (I): (Chemical formula should be inserted here as it appears on abstract in paper form) Formula (I) as disclosed herein, or a pharmaceutically acceptable salt, solvate, ester, prodrug or stereoisomer thereof. Also disclosed are pharmaceutical compositions comprising said compounds, and methods for using said compounds for treating or preventing a thromboembolic disorder.
本发明涉及一种新的
杂环化合物,其
化学式为(I):(
化学式应按纸质摘要中的形式插入此处)如本文所述的化合物(I)或其药学上可接受的盐、溶剂合物、
酯、前药或立体异构体。本文还揭示了包括所述化合物的制药组合物,以及使用所述化合物治疗或预防血栓栓塞性疾病的方法。